spot on 10mc..surely dendreon just completing phase3 trials for provenge would br interested in swooping on cvac which is just going into phase3 trials.it would give them full control over this type of therapy on the market in the coming years.
roger the dodger hitting the bio conference in the U.S and wonder if he'll bump into dendreon or any other pharma looking for the opportunity that cvac presents.
partners with denedron, page-2
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.005(1.47%) |
Mkt cap ! $501.1M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.5¢ | 32.5¢ | $659.6K | 1.969M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 399004 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 4457 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |